Michael J Parini has been appointed to the newly-created role of president and chief operating officer at UK-based Freeline Therapeutics Plc, a developer of gene therapies. The company has also announced the departure of Brian M Silver, its chief financial officer and head of corporate development, who has decided to leave Freeline for a new opportunity.
Mr Parini will be based in the US, and will support the chief executive in developing global strategy. He joins Freeline from Vertex Pharmaceuticals Inc, where he worked for five years, after more than a decade at Pfizer Inc.
Freeline Therapeutics announced the appointment on 16 February 2021
Copyright 2021 Evernow Publishing Ltd